NEW YORK (GenomeWeb News) – Charles River Laboratories has completed its purchase of the BioFocus and Argenta service division operations from Galapagos for up to €134 million ($184 million). As part of the deal announced in March, Charles River paid Galapagos €129 million upfront and will pay potentially up to another €5 million upon the achievement of a revenue target 12 months after the closing of the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.